Last updated: July 17, 2026

Application No. 18/693,310

BENZIMIDAZOLES AS MODULATORS OF IL-17

Non-Final OA

Filed

Mar 19, 2024

Priority

Sep 27, 2021 — provisional 63/248,569 +1 more

Examiner

ROCHELLE, CIERRA MARIE

Art Unit

1627

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Janssen Pharmaceutica N.V.

OA Round

1 (Non-Final)

Examiner Intelligence

ROCHELLE, CIERRA MARIE View full profile →

Grants only 0% of cases

Career Allowance Rate

0 granted / 0 resolved

-60.0% vs TC avg

Minimal +0% lift

Without

With

+0.0%

Interview Lift

resolved cases with interview

Typical timeline

Avg Prosecution

9 currently pending

Career history

Total Applications

across all art units

Statute-Specific Performance

§101

15.4%

-24.6% vs TC avg

§103

42.3%

+2.3% vs TC avg

§112

11.5%

-28.5% vs TC avg

Black line = Tech Center average estimate • Based on career data from 0 resolved cases

Prosecution Timeline

Mar 19, 2024

Application Filed

May 05, 2026

Non-Final Rejection mailed (current)

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

Grant Probability

Low

PTA Risk

Based on 0 resolved cases by this examiner. Grant probability derived from career allowance rate.